LIVN LivaNova Earnings and EPS analysis

Relative Growth: Rel. Growth: 76

Relative Strength: Rel. Strength: 71

Relative Valuation: Rel. Valuation: 64

Relative Profitability: Rel. Profitability: 90

EPS in 2026 (TTM): $1.96

Last Report Period Date: Mar 31, 2026

As of June 2026, according to LivaNova's latest financial report, the company's current EPS (TTM) is $1.96. In 2025, the company recorded an earnings per share (EPS) of -$4.45, which represents a decrease compared to its EPS of $1.17 in 2024. LivaNova's earnings per share for the quarterly report ending on Mar 31, 2026 was $0.41.

LIVN earnings history

Historical annual and quarterly earnings per share (EPS) data for LivaNova

EPS (TTM)

$1.96

EPS Growth YoY (Quarterly)

106.8%

EPS (Quarterly)

$0.41

EPS Growth (Quarterly)

-26.8%

The annual EPS in 2025 was -$4.45, a decrease of 480.3% from $1.17 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.41, showing a 106.8% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $1.96. In 2024, the annual EPS was $1.17, showing an increase of 254.5% from 2023.

LIVN earnings chart

LIVN EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

106.8%

EPS growth YoY

-480.3%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

LivaNova has recorded an increase in EPS of 106.8% over the last 12 months (YoY, quarterly).

LIVN Earnings Waterfall

Breakdown of revenue, profit and net income for LivaNova

LIVN Earnings vs Peers

What are the earnings of LIVN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
LIVN LivaNova PLC	37.62	-480.3%	N/A	N/A
OFIX Orthofix Medical Inc	N/A	29.4%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.